In the News – Merck Updates Propecia Side Effect Warnings
Snippet from the article:
Warning labels for Merck & Co’s drugs for baldness and enlarged prostate will add notices of sexual side effects that continued after use of the medicines was stopped, U.S. health regulators said.
Labels will be revised for Proscar, which treats symptoms of enlarged prostate, and hair-loss treatment Propecia, the Food and Drug Administration said. The active ingredient in both drugs is finasteride.
The Propecia label will now include notification of problems with libido, ejaculation and orgasms that continued after use of the drug was ended. Proscar’s label will include notification of decreased libido.
Read the rest — Sexual side effect warnings added to Merck drugs
This is the first baby step in the direction which the medical community is heading. The recent decision was based on the selection of post-marketing reports that they received from patients, doctors, and Merck. When different sources of evidence become known in the medium-term, the FDA will continue to take appropriate action.
Lol. I came back to see how you guys were responding to the warning change from the FDA and I see you are accusing other posters of being me. Just as I said would happen months ago, the FDA took some steps to strengthen the warning label due to the reports they received on their med watch database. For some reason Tex and BiotecMD tried to claim they researched this and said there was no evidence of such reports. It is somewhat ironic that some of you have the nerve to accuse me of being a “troll”. More research is currently underway and more studies are slated to start in the next year or two. I do not expect that Dr. Rassman knows anything about this or even cares since he is merely a hair transplant professional. I am pretty much done with this blog since sadly the majority of you are so caught up in your hair loss that there is no willingness to discuss these matters seriously but
I wanted to check in and hope you are all healthy.
J